Company Filing History:
Years Active: 2017
Title: Jeom Soon Shim: Innovator in Nanoparticle Toxicity Diagnosis
Introduction
Jeom Soon Shim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of nanoparticle toxicity diagnosis. His innovative work focuses on developing biomarkers that can effectively evaluate the toxicity of nanoparticles, which is crucial for health and safety assessments.
Latest Patents
Jeom Soon Shim holds a patent titled "Biomarker for diagnosing toxicity of nanoparticles and method for evaluating toxicity of nanoparticles using the same." This patent discloses a biomarker composition that shows a change in expression when exposed to nanoparticles. The composition includes at least one gene selected from a specific group, which correlates highly with nanoparticle toxicity. The method developed allows for high detection sensitivity in determining whether nanoparticles are toxic. This innovation is essential for monitoring and evaluating the health effects of nanoparticles.
Career Highlights
Jeom Soon Shim is affiliated with the Ajou University Industry-Academic Cooperation Foundation. His work at this institution emphasizes the importance of research and collaboration in advancing scientific knowledge. His contributions have been recognized in the field of toxicology, particularly concerning the health implications of nanoparticles.
Collaborations
Jeom Soon Shim has collaborated with notable colleagues, including Woo Young Shim and Duc Toan Nguyen. These partnerships have enhanced the research and development of innovative solutions in the field of nanoparticle toxicity.
Conclusion
Jeom Soon Shim's work in developing biomarkers for nanoparticle toxicity diagnosis represents a significant advancement in health and safety research. His contributions are vital for understanding the implications of nanoparticles on human health.